Article
Effects of Pycnogenol<sup>®</sup>in post-COVID-19 condition (PYCNOVID): A single-center, placebo controlled, quadruple-blind, randomized trial
2025-06-20
Abstract excerpt
<h4>Background</h4> Post-COVID-19 condition (PCC) remains a public health challenge with limited treatment options. <h4>Objective</h4> To evaluate the effects of Pycnogenol ® , a French maritime pine bark extract with anti-inflammatory and antioxidative properties, versus placebo on patient-reported health status in individuals with PCC. <h4>Design</h4> Single-center, placebo-controlled, quadruple-blind, randomize...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 206f7edd-8d8e-54de-90c9-12582ce172bc
- DOI
- 10.1101/2025.06.12.25329489
